Mobile app-based telecare system for hypertension management in China and Argentina
Official title: Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
Run by Istituto Auxologico Italiano · NCT03206814 · Data updated 2026-11-12
This study is testing a new mobile app to help people with high blood pressure in China and Argentina manage their condition better alongside regular doctor visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 480 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 8 sites (Bahía Blanca and 7 other locations) |
| Status | Recruiting |
| Started | May 11, 2021 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | February 27, 2025 |
| Trial ID | NCT03206814 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-80 with uncontrolled hypertension who have access to a compatible smartphone.
✕Probably not a fit
Patients with severe uncontrolled hypertension or significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CHARGE-APP project aims to evaluate an innovative hypertension management strategy that combines standard care visits with the ESH CARE app, compared to traditional care alone. This one-year, randomized, open-label study will enroll patients with uncontrolled hypertension and monitor their blood pressure and related health outcomes over time. Participants will be randomly assigned to either the new management strategy, which includes remote monitoring of home blood pressure readings, or to usual care with regular clinic visits. The study will assess changes in various blood pressure metrics and cardiovascular health indicators throughout the follow-up period.
Why it matters
Potential benefit: If successful, this approach could significantly improve hypertension control and patient outcomes through enhanced monitoring and management.
How similar studies have gone: Other studies have shown promise with mobile health interventions for hypertension management, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female subjects; * Age 18-80 years; * Either the patient or another person close to him/her should possess a smartphone compatible with the ESH CARE app and be capable of using it; * Uncontrolled (untreated or treated) hypertension, defined as office BP ≥140/90 mmHg, and Ambulatory 24h ABP ≥130/80 mmHg Exclusion Criteria: * eGFR \<45 mL/min/1.73 m2 (CKD-EPI creatinine equation 2009); * Severe uncontrolled hypertension (i.e. BP ≥200/120 mmHg despite treatment); * Known secondary hypertension; * Orthostatic hypotension (SBP fall \> 20 mmHg on standing); * Unstable clinical conditions or severe disease with short life expectation; * Known atrial fibrillation; * Hepatic disease as determined by either AST or ALT values \> 2 times the upper limit of normal; * History of gastrointestinal surgery or disorders which could interfere with drug absorption * History of malignancy including leukaemia and lymphoma (but not basal cell skin cancer) within the last 5 years; * History of clinically significant autoimmune disorders such as systemic lupus erythematosus; * History of drug or alcohol abuse within the last 5 years; * History of non-compliance to medical regimens and/or patients who are considered potentially unreliable; * Dementia (clinical diagnosis); * Inability or unwillingness to give free informed consent; * Inability to use even simple communication technologies; * Pregnancy or planned pregnancy during study period
Where it's running
-
Private Hospital " Dr Raúl Matera"
Bahía Blanca, Argentina Recruiting -
Argerich Hospital
Buenos Aires, Argentina Recruiting -
General San Martin Hospital of La Plata
La Plata, Argentina Recruiting -
Spanish Hospital of Mendoza
Mendoza, Argentina Recruiting -
British Sanatorium of Rosario
Rosario, Argentina Recruiting -
Shanghai Institute of Hypertension
Shanghai, Huangpu, China Recruiting
Show 2 more locations
-
Ruijin Hospital North
Shanghai, China Recruiting -
Jiangsu Province Official Hospital
Jiangse, China Active not recruiting
Study contacts
- Principal investigator: Gianfranco Parati, MD — Istituto Auxologico Italiano
- Study coordinator: Gianfranco Parati, MD
- Email: gianfranco.parati@unimib.it
- Phone: +390261911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing renal denervation for uncontrolled hypertension
This study is testing if a new method of renal denervation that uses real-time feedback can help people with high blood pressure more effectively than the standard approach.
-
Effect of Songling Xuemaikang Capsules on mild hypertension
This study tests whether Songling Xuemaikang Capsules can help people with mild high blood pressure improve their heart and blood vessel health compared to a lifestyle change or a placebo.
-
Mobile health program to manage hypertension in rural areas
This study tests a home-based program that helps people in rural areas with high blood pressure by providing personalized coaching and health education to see if it improves their health.
-
Evaluating the effectiveness and safety of fixed-dose combinations for treating essential hypertension
This study is testing if a new combination of blood pressure medications can help people with high blood pressure feel better and stay healthy over time.
-
Exploring the Benefits of Natural Medicine and Vitamin IV Therapy
This study is testing whether herbal medicine and vitamin IV therapy can help improve health and manage chronic conditions like anxiety, fibromyalgia, and arthritis.
-
Using advanced imaging to analyze retinal vascular diseases
This study is testing new imaging techniques to see how they can help doctors understand and track the progress of retinal diseases like diabetic retinopathy in both healthy people and those affected by these conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.